Clinical Trial Update: Phase 1 Novel Live Attenuated Serotype 2 Oral Polio Vaccine Study in Inactivated Polio Vaccine (IPV) Primed Adults [Phase 1]

View source ↗

Summary

Phase 1 study of a novel live attenuated serotype 2 oral polio vaccine in adults primed with IPV showed completed status with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• live attenuated serotype 2 oral polio vaccine (OPV2) study

Snippet

Sponsor: Pierre Van Damme | Conditions: Poliomyelitis | Phase 1 | Status: COMPLETED | Results posted: 2021-02-04